| WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group. Association between administration of IL-6 antagonists and mortality among patients hospitalized for … M Shankar-Hari, CL Vale, PJ Godolphin, D Fisher, JPT Higgins, F Spiga, ... jama 326 (6), 499-518, 2021 | 496* | 2021 |
| Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial PM Bath, P Scutt, CS Anderson, JP Appleton, E Berge, L Cala, M Dixon, ... The Lancet 393 (10175), 1009-1020, 2019 | 158 | 2019 |
| Prehospital transdermal glyceryl trinitrate for ultra-acute intracerebral hemorrhage: data from the RIGHT-2 trial PM Bath, LJ Woodhouse, K Krishnan, JP Appleton, CS Anderson, ... Stroke 50 (11), 3064-3071, 2019 | 47 | 2019 |
| Iron preparations for women of reproductive age with iron deficiency anaemia in pregnancy (FRIDA): a systematic review and network meta-analysis E Rogozińska, J Daru, M Nicolaides, C Amezcua-Prieto, S Robinson, ... The Lancet Haematology 8 (7), e503-e512, 2021 | 39 | 2021 |
| A framework for prospective, adaptive meta-analysis (FAME) of aggregate data from randomised trials JF Tierney, DJ Fisher, CL Vale, S Burdett, LH Rydzewska, E Rogozińska, ... PLoS medicine 18 (5), e1003629, 2021 | 23 | 2021 |
| Which patients with metastatic hormone-sensitive prostate cancer benefit from docetaxel: a systematic review and meta-analysis of individual participant data from randomised trials CL Vale, DJ Fisher, PJ Godolphin, LH Rydzewska, JM Boher, S Burdett, ... The Lancet Oncology 24 (7), 783-797, 2023 | 21 | 2023 |
| Association between tocilizumab, sarilumab and all-cause mortality at 28 days in hospitalised patients with COVID-19: A network meta-analysis PJ Godolphin, DJ Fisher, LR Berry, LPG Derde, JV Diaz, AC Gordon, ... PLoS One 17 (7), e0270668, 2022 | 19 | 2022 |
| Defining more precisely the effects of docetaxel plus ADT for men with mHSPC: Meta-analysis of individual participant data from randomized trials. CL Vale, D Fisher, P Godolphin, LH Rydzewska, JM Boher, S Burdett, ... Journal of Clinical Oncology 40 (16_suppl), 5070-5070, 2022 | 18 | 2022 |
| The reporting standards of randomised controlled trials in leading medical journals between 2019 and 2020: a systematic review M McErlean, J Samways, PJ Godolphin, Y Chen Irish Journal of Medical Science (1971-) 192 (1), 73-80, 2023 | 16 | 2023 |
| Outcome assessment by central adjudicators versus site investigators in stroke trials: a systematic review and meta-analysis PJ Godolphin, PM Bath, A Algra, E Berge, MM Brown, J Chalmers, ... Stroke 50 (8), 2187-2196, 2019 | 14 | 2019 |
| Estimating interactions and subgroup‐specific treatment effects in meta‐analysis without aggregation bias: A within‐trial framework PJ Godolphin, IR White, JF Tierney, DJ Fisher Research Synthesis Methods 14 (1), 68-78, 2023 | 10 | 2023 |
| Robustness of crossover trials against subject drop-out–examples of perpetually connected designs PJ Godolphin, EJ Godolphin Statistical methods in medical research 28 (3), 788-800, 2019 | 10 | 2019 |
| Identifying women giving birth preterm and care at the time of birth: a prospective audit of births at six hospitals in India, Kenya, Pakistan and Uganda EJ Mitchell, S Benjamin, S Ononge, J Ditai, Z Qureshi, SN Masood, ... BMC pregnancy and childbirth 20, 1-10, 2020 | 9 | 2020 |
| Short email with attachment versus long email without attachment when contacting authors to request unpublished data for a systematic review: a nested randomised trial PJ Godolphin, PM Bath, AA Montgomery BMJ open 9 (1), e025273, 2019 | 9 | 2019 |
| Outcome assessment by central adjudicators in randomised stroke trials: simulation of differential and non-differential misclassification PJ Godolphin, PM Bath, C Partlett, E Berge, MM Brown, M Eliasziw, ... European Stroke Journal 5 (2), 174-183, 2020 | 8 | 2020 |
| Central adjudication of serious adverse events did not affect trial’s safety results: data from the Efficacy of Nitric Oxide in Stroke (ENOS) trial PJ Godolphin, AA Montgomery, LJ Woodhouse, D Bereczki, E Berge, ... PLoS One 13 (11), e0208142, 2018 | 8 | 2018 |
| Standard care informed by the result of a placental growth factor blood test versus standard care alone in women with reduced fetal movement at or after 36+ 0 weeks’ gestation … L Armstrong-Buisseret, PJ Godolphin, L Bradshaw, E Mitchell, S Ratcliffe, ... Pilot and feasibility studies 6, 1-14, 2020 | 7 | 2020 |
| Development of a checklist of standard items for processing individual participant data from randomised trials for meta-analyses: Protocol for a modified e-Delphi study KE Hunter, AC Webster, M Clarke, MJ Page, S Libesman, PJ Godolphin, ... Plos one 17 (10), e0275893, 2022 | 6 | 2022 |
| Do investigator meetings improve recruitment rates in clinical trials? A retrospective before-and-after study of data from nine multi-centre clinical trials EJ Mitchell, PJ Godolphin, G Meakin, K Sprange Trials 21, 1-7, 2020 | 6 | 2020 |
| Cost-benefit of outcome adjudication in nine randomised stroke trials PJ Godolphin, PM Bath, A Algra, E Berge, J Chalmers, M Eliasziw, ... Clinical Trials 17 (5), 576-580, 2020 | 6 | 2020 |
Ewelina Rogozinska, PhDMRC Clinical Trials Unit at UCLVerified email at ucl.ac.uk
